FDA Approved: AGAMREE — Supplemental Application (Catalyst Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved a supplemental application for AGAMREE (vamorolone) submitted by Catalyst Pharmaceuticals, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Duchenne Muscular Dystrophy

Drugs mentioned

• AGAMREE (Vamorolone)

Snippet

SUPPL AP for AGAMREE (VAMOROLONE)